Advances in Myelofibrosis Treatment and Enhancing Patient Quality of Life : Episode 3

Educational Resources for Patients Diagnosed With Myelofibrosis

January 31, 2024

By Christine Cooper, RN, BSN
Aaron T. Gerds, MD, MS

Opinion

Video

Patients should be directed to resources like the NCCN guidelines and ClinicalTrials.gov and provided with thorough discussions covering frequency of visits, required testing, medication administration, side effects to enable fully informed decisions.

EP: 1.Diagnosing Myelofibrosis

EP: 2.Assessing Risk Level of Patients With Myelofibrosis

EP: 3.Educational Resources for Patients Diagnosed With Myelofibrosis

EP: 4.Key Patient Goals for Myelofibrosis Management

EP: 5.Management of Anemia in Patients With Myelofibrosis

EP: 6.Clinical Data on the Approved JAK Inhibitors for Treatment of Myelofibrosis

EP: 7.Adverse Events Seen With JAK Inhibitors for Myelofibrosis

EP: 8.Assessing Treatment Response in Patients With Myelofibrosis

EP: 9.Best Approaches to Switching Therapies for a Patient With Myelofibrosis

EP: 10.Dosing JAK Inhibitors in Patients With Myelofibrosis

EP: 11.Key Takeaways for Patients With Myelofibrosis

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos

Photo of a man wearing a suit in front of an Oncology Nursing News backdrop

2 experts are featured in this series.

2 experts are featured in this series.

Latest Conference Coverage

Safety Management With Amivantamab Plus Lazertinib in NSCLC

Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLC

Adverse Events of Menin Inhibitors in AML: What Nurses Should Know

Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC

View More Latest Conference Coverage

Editorial Board

CancerNetwork.com

TargetedOnc.com

Terms & Conditions

Do Not Sell My Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences

All rights reserved.